Figure Gallery

Expression Pattern Search Results for tbx5a

(155 figures with expression from 96 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Holly et al., 2014	Fig. 8	WT	standard conditions	10-13 somites	optic vesicle dorsal region
Lee et al., 2014	Fig. 5	AB AB + MO1-atg7 AB + MO2-becn1 AB + MO4-atg5	standard conditions control	Protruding-mouth	heart
Pi-Roig et al., 2014	Fig. 5	WT WT + MO1-tbx5b	standard conditions control	Prim-5	mesoderm pectoral fin bud
Choudhry et al., 2013	Fig. S5	WT tbx1^tm208/tm208	standard conditions control	Long-pec	atrium cardiac ventricle
Lam et al., 2013	Fig. 3	WT WT + MO3-osr2 + MO4-osr2	standard conditions control	Prim-15 to Protruding-mouth	mesenchyme pectoral fin
Novikov et al., 2013	Fig. 8	WT WT + MO3-tmem88a + MO4-tmem88a	standard conditions control	20-25 somites	pectoral fin field
Parrie et al., 2013	Fig. 7	WT tbx5a^m21/m21 WT + MO1-tbx5b	standard conditions standard conditions	Prim-15 to Prim-25	whole organism
Wieffer et al., 2013	Fig. S3	AB AB + MO1-pi4k2b w32Tg	standard conditions standard conditions heat shock chemical treatment: SU5402	20-25 somites to Prim-5	pectoral fin bud pectoral fin field
Wu et al., 2013	Fig. 4	TU	chemical treatment: flame retardant	Protruding-mouth	whole organism
Boisset et al., 2012	Fig. 6	WT WT + MO1-hmx1	standard conditions standard conditions	Prim-5	optic cup dorsal region
Neto et al., 2012	Fig. 3	WT WT + MO1-osr1 WT + MO1-osr2 WT + MO1-osr1 + MO1-osr2	standard conditions standard conditions standard conditions control	5-9 somites to Prim-5	eye pectoral fin field
	Fig. 4	WT WT + MO1-osr1 + MO1-osr2	standard conditions control	Prim-5	pectoral fin bud
	Fig. 8	WT WT + MO1-osr1 + MO1-osr2	control chemical treatment: all-trans-retinoic acid, chemical treatment: pharmaceutical chemical treatment: all-trans-retinoic acid chemical treatment: pharmaceutical	20-25 somites	pectoral fin field
	Fig. 7	WT WT + MO3-wnt2ba	standard conditions control	10-13 somites	pectoral fin field
	Fig. 2	WT	standard conditions	5-9 somites to Protruding-mouth	lateral plate mesoderm pectoral fin
	Fig. 9	WT	control chemical treatment: pharmaceutical	20-25 somites	pectoral fin field
van der Velden et al., 2012	Fig. 8	WT apc^hu745/hu745 rnf2^ibl30/ibl30 rnf2^ibl31/ibl31 apc^hu745/hu745; rnf2^ibl30/ibl30 apc^hu745/hu745; rnf2^ibl31/ibl31	standard conditions	Prim-15 to Protruding-mouth	pectoral fin
	Fig. 2	WT rnf2^ibl30/ibl30 rnf2^ibl31/ibl31	standard conditions	Prim-15	pectoral fin bud
	Fig. 3	WT rnf2^ibl30/ibl30 rnf2^ibl31/ibl31	standard conditions	14-19 somites to Prim-25	mesenchyme pectoral fin pectoral fin bud pectoral fin field
	Fig. 4	WT rnf2^ibl30/ibl30 rnf2^ibl31/ibl31	standard conditions	10-13 somites to 14-19 somites	lateral plate mesoderm
	Fig. 7	WT rnf2^ibl30/ibl30 rnf2^ibl31/ibl31	standard conditions	Prim-25	pectoral fin bud
	Fig. S3	WT rnf2^ibl30/ibl30 rnf2^ibl31/ibl31	standard conditions	Prim-15 to Long-pec	mesenchyme pectoral fin nucleus
	Fig. S4	WT WT + MO1-rnf2 WT + MO2-rnf2	standard conditions standard conditions standard conditions	Long-pec	head pectoral fin
He et al., 2011	Fig. 4	AB/TU AB/TU + MO1-rarab	standard conditions control	20-25 somites	heart rudiment immature eye pectoral fin field
	Fig. S5	AB/TU	control chemical treatment by environment: 4-(diethylamino)benzaldehyde	Prim-5	eye heart tube pectoral fin bud